Fox Chase Cancer Center News

CHICAGO (May 21, 2015) — Although recent survey participants expressed an interest in comprehensive tumor genetic profiling (CGP)—a novel technology to help identify mutations in pathologically relevant cancer genes for targeted therapy—the participants with lower income, less education, and non-private insurance were less likely to pursue CGP if out-of-pocket costs were involved, according to recent study findings.

CHICAGO (May 20, 2015) — Cancer patients are increasingly having their tumors tested using comprehensive genomic profiling (CGP) to identify genetic mutations that can be targeted by precision therapies. A new study from investigators at Fox Chase Cancer Center in collaboration with Foundation Medicine has shown that 3-7% of patients receiving CGP could have a genetic mutation that they inherited from a parent that can also be identified using results from next generation sequencing (NGS)-based CGP.

CHICAGO (May 19, 2015) — African-American patients have a disproportionately high rate of cancer, and yet are less likely than Caucasian patients to participate in oncologic clinical trials that can significantly improve quality of life. Researchers from Fox Chase Cancer Center and Temple University recently explored the differences between African Americans who did and did not participate in a clinical trial and found significant discrepancies in perceptions and beliefs between the two groups. Lead study author Daniel M. Geynisman, MD, attending physician and assistant professor of medical oncology at Fox Chase, will present these findings during a poster session on Monday, June 1 at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago.

CHICAGO (May 18, 2015) — Although various drugs have improved outcomes for metastatic colon cancer patients, researchers continually strive to find new agents to improve treatment. Antibody-drug conjugates are a promising option, due to the fact that they can deliver chemotherapy directly into a targeted cell and destroy tumor cells while keeping healthy ones intact.

Immersion Science Health Careers Symposium 2015 Offers Professional Presentations and Interactive Experience

PHILADELPHIA (May 10, 2015)—Faculty and staff, volunteers, patients, survivors, and their families will come together as members of the Fox Chase Cancer Center/Temple Health team at Susan G. Komen Philadelphia’s 25th Annual Race for the Cure on Mother’s Day—Sunday, May 10, 2015.

Philadelphia, PA (April 27, 2015) – Sixty-one (61) Temple physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2015.  Physicians on the list were nominated by their professional peers, and practice at Temple University Hospital, Fox Chase Cancer Center, Jeanes Hospital and in the community as part of Temple Physicians, Inc.

PHILADELPHIA (April 17, 2015)— A new surgical approach that removes the fallopian tubes while sparing the ovaries may provide premenopausal women at high risk for ovarian cancer, particularly those with BRCA1/2 mutations, with a cancer risk–minimizing surgical option that also reduces some negative effects of ovary removal at a young age, according to a review published in the May issue of Cancer Prevention Research, a journal of the American Association for Cancer Research.